Featured Research

from universities, journals, and other organizations

Project Bioshield: Researchers To Develop Anti-Radiation Treatments

Date:
September 26, 2006
Source:
NIH/National Institute Of Allergy And Infectious Diseases
Summary:
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has issued five awards totaling $4 million to fund the development of products that eliminate radioactive materials from the human body following radiological or nuclear exposure. The awards, which were granted under Project Bioshield authorities, complement NIAID's other medical countermeasure efforts to create safe and effective products of this type.

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has issued five awards totaling $4 million to fund the development of products that eliminate radioactive materials from the human body following radiological or nuclear exposure. The awards, which were granted under Project Bioshield authorities, complement NIAID's other medical countermeasure efforts to create safe and effective products of this type.

Related Articles


"These new grants will help identify new drug candidates that could be acquired by the strategic national stockpile of medical countermeasures, which is available to the public after a terrorist or nuclear attack or accidental radioactive exposure," says NIAID Director Anthony S. Fauci, M.D.

In the event of an attack by a nuclear explosive device or radiological "dirty bomb," individuals potentially could inhale, ingest or absorb through their skin radioactive atoms called radionuclides. Depending on the type of radionuclide that a person is exposed to, the particles may be excreted from the body or enter bones, organs or other tissues, which could have significant adverse health consequences. Through an initiative announced in 2005, NIAID already is working to speed the development of a series of products that can bind (chelate) internally with the radionuclides and eliminate (decorporate) them from the body. Radionuclide decorporation products currently are available in the strategic national stockpile, but NIAID is focusing on expanding the product pool, creating new treatments capable of eliminating a wider range of radionuclides, developing products that can eliminate radioactive material faster and in greater amounts; and developing products in formulations that could be distributed more easily in a mass casualty situation.

NIAID has awarded five grants totaling up to $4 million to fund work for a period of 18 months. The following principal investigators and universities are the recipients of the grants:

* Raymond J. Bergeron, Ph.D., University of Florida, Gainesville, $1.0 million

* Tatiana G. Levitskaia, Ph.D., Pacific Northwest National Laboratory, Richland, WA, $725,000

* Scott C. Miller, Ph.D., University of Utah School of Medicine, Salt Lake City, $675,000

* Kenneth N. Raymond, Ph.D., University of California/Lawrence Berkeley National Laboratory, Berkeley, CA, $998,325

* Charles Timchalk, Ph.D., Pacific Northwest National Laboratory, Richland, WA, $599,747

"The goal of this new program is to accelerate the development of previously identified, promising compounds into effective products that could be licensed for use," says program officer Bert Maidment, Ph.D., associate director of product development in NIAID's Division of Allergy, Immunology and Transplantation.

NIAID issued the grants under authority provided by Project Bioshield, which was signed into law in 2004. Its enactment provided federal agencies with new tools to speed research on medical countermeasures to protect Americans against chemical, biological, radiological or nuclear attack.


Story Source:

The above story is based on materials provided by NIH/National Institute Of Allergy And Infectious Diseases. Note: Materials may be edited for content and length.


Cite This Page:

NIH/National Institute Of Allergy And Infectious Diseases. "Project Bioshield: Researchers To Develop Anti-Radiation Treatments." ScienceDaily. ScienceDaily, 26 September 2006. <www.sciencedaily.com/releases/2006/09/060925163456.htm>.
NIH/National Institute Of Allergy And Infectious Diseases. (2006, September 26). Project Bioshield: Researchers To Develop Anti-Radiation Treatments. ScienceDaily. Retrieved April 1, 2015 from www.sciencedaily.com/releases/2006/09/060925163456.htm
NIH/National Institute Of Allergy And Infectious Diseases. "Project Bioshield: Researchers To Develop Anti-Radiation Treatments." ScienceDaily. www.sciencedaily.com/releases/2006/09/060925163456.htm (accessed April 1, 2015).

Share This


More From ScienceDaily



More Matter & Energy News

Wednesday, April 1, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

7-Year-Old Girl Gets 3-D Printed 'robohand'

7-Year-Old Girl Gets 3-D Printed 'robohand'

AP (Mar. 31, 2015) Although she never had much interest in prosthetic limbs before, Faith Lennox couldn&apos;t wait to slip on her new robohand. The 7-year-old, who lost part of her left arm when she was a baby, grabbed it as soon as it came off a 3-D printer. (March 31) Video provided by AP
Powered by NewsLook.com
Dutch Architects Show Off 3D House-Building Prowess

Dutch Architects Show Off 3D House-Building Prowess

Reuters - Innovations Video Online (Mar. 31, 2015) Dutch architects are constructing a 3D-printed canal-side home, which they hope will spark an environmental revolution in the house-building industry. Jim Drury reports. Video provided by Reuters
Powered by NewsLook.com
Solar Plane Stops in China

Solar Plane Stops in China

Reuters - News Video Online (Mar. 31, 2015) Solar Impulse 2 stops over in China&apos;s Chonqing, completing the fifth leg in its bid to become the first solar powered plane to travel around the globe. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Solar Impulse Lands in China After 20-Hour Flight from Myanmar

Solar Impulse Lands in China After 20-Hour Flight from Myanmar

AFP (Mar. 31, 2015) Solar Impulse 2 lands in China, the world&apos;s biggest carbon emitter, completing the fifth leg of its landmark global circumnavigation powered solely by the sun. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Space & Time

Matter & Energy

Computers & Math

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins